Table 15.
Summary of ruthenium(III) complexes coordinated to O N O ligands with better IC50 values (μM) in different cell lines.
Compound |
Metal geometry |
Exposure time [h] |
Cell lines |
IC50 value [μM] |
Main feature |
Ref. |
---|---|---|---|---|---|---|
Ru‐01 |
Octahedral |
24 |
Hep‐G2 |
20±0.2 |
The anticancer activity depends on the metal centre. In this case, ruthenium outperformed platinum. |
[125] |